In modern diagnostics, decision makers often face uncertainty when selecting molecular recognition tools that balance precision, stability, and scalability. The shift toward nucleic acid based recognition systems has intensified this debate across clinical and research environments. Within this evolving landscape, the aptamer market forecast is becoming a central reference point for...